Similarly, TF+ DU-145 cells exhibited stronger propensity to clonogenic survival and growth than their TF- counterparts (Figure 3D and 3E) indicating that TF-Ag selection does enrich for prostate cancer cells with enhanced clonogenicity. The gene discussed is RENBP; the disease is prostate cancer.